• Nanette K Wenger, Keith C Ferdinand, Bairey MerzC NoelCNDepartment of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, Calif., Mary Norine Walsh, Martha Gulati, Carl J Pepine, and American College of Cardiology Cardiovascular Disease in Women Committee.
• Department of Cardiology, Emory University School of Medicine Atlanta, Ga.
• Am. J. Med. 2016 Oct 1; 129 (10): 103010361030-6.

AbstractHypertension accounts for approximately 1 in 5 deaths in American women and is the major contributor to many comorbid conditions. Although blood pressure lowering reduces cardiovascular disease outcomes, considerable uncertainty remains on best management in women. Specifically, female blood pressure treatment goals have not been established, particularly among older and African American and Hispanic women, for whom hypertension prevalence, related adverse outcomes, and poor control rates are high. The Systolic Blood Pressure Intervention Trial (SPRINT) planned to clarify optimal blood pressure management in both sexes. Although confirming that a lower blood pressure goal is generally better, because female enrollment and event rates were low and follow-up shortened, outcomes differences in women were not statistically significant. Thus optimal blood pressure goals for women have not been established with the highest evidence. This review addresses SPRINT's significance and key remaining knowledge gaps in optimal blood pressure management to improve women's health.Copyright © 2016 Elsevier Inc. All rights reserved.

23 keywords...

hide…